local_hospital

ASST Ospedale Maggiore di Crema

Address
lock Available on a paid plan

Neoplasms Research at ASST Ospedale Maggiore di Crema

Clinical trial activity at ASST Ospedale Maggiore di Crema focuses on neoplasms, with studies spanning several major cancer types. The research is centered on improving treatment choices, testing new therapies, and refining how care is tailored for different patients.

  • Breast cancer research in premenopausal women with HR-positive/HER2-negative disease, looking at personalized treatment strategies and the value of biomarker-guided decisions.
  • Colorectal cancer studies in stage III and high-risk stage II disease, including work on circulating tumor DNA to guide postoperative treatment and improve disease control.
  • Melanoma trials for unresectable or metastatic disease, evaluating new immunotherapy options against established treatment approaches.
  • Pancreatic cancer research in advanced disease, assessing treatment strategies intended to improve survival and maintain effectiveness over time.
  • Non-small cell lung cancer studies exploring ways to reduce poor treatment responses such as hyperprogression and early death, with a focus on better immunotherapy outcomes.

Overall, the site supports oncology research aimed at advancing diagnostics, strengthening treatment effectiveness, and helping match cancer therapy more closely to patient risk and tumor biology.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
18
IMPs

Activity Indicator

Last 6 months

0
Trials started
-100% vs previous period.
1
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_downDeclining-100%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 1 therapeutic areas and 15 of 18 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
2
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 566 other sites in Italy

description
Trial volume
2
Outperforms 36% of sites
public
Therapeutic diversity
1areas
Outperforms 1% of sites
groups
Sponsor diversity
2sponsors
Outperforms 37% of sites

Therapeutic Area Benchmark — Italy

Select a therapeutic area to compare against other sites in Italy.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Italy

Market Share

Country: Italy

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in ASST Ospedale Maggiore di Crema

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of ctDNA Clearance in Stage III and High-Risk Stage II Resected Colon Cancer Using FOLFOXIRI, Trifluridine/Tipiracil, and Drug CombinationsFondazione GONO G.I.Phase IINot Yet RecruitingMar 2023

IMP list

lock Showing 1 of 18 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Anastrozole1Unknown2026-04-232026-04-23

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.